Skip to main content
FMCFMC CorporationSell4.3·$11.60+1.93%
SellModerate Confidence
Investment thesis

The stock trades at a forward price-to-earnings multiple of 5.2x with roughly 33% headroom to the analyst consensus target and has beaten or matched estimates in all four of the last four reported quarters, but quality sits well below the minimum threshold — a Piotroski score of 3 out of 9, no competitive moat — revenue is contracting 4% year over year, a confirmed death-cross technical pattern has triggered a hard block, and 18% short interest signals that the market views the depressed multiple as earned rather than as a value opportunity.

Thesis pillars

  • Death Cross Falling Knife DowntrendStable
  • Deep Discount Offset By Justified Short InterestStable
  • Quality Floor Breach Weak FundamentalsStable
  • +1 more pillar — see the Why tab for full reasoning

Full reasoning →

Open full analysis

FMC Corporation (FMC) Stock Analysis

Recovery setup · Catalyst-Driven edge

SellVALUE-TRAP 1/5Moderate Confidence

Basic Materials · Agricultural Inputs

Sell if holding. Engine safety override at $11.60: Quality below floor (1.7 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.3/10 and A.R:R 2.3:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 21%; Below-average business quality; Below long-term trend.

FMC Corporation develops, markets, and sells crop protection chemicals — insecticides, herbicides, fungicides — plus biologicals and plant health products in a single global segment, employing approximately 5,500 people across four regions. Revenue comes from proprietary active... Read more

$11.60+28.1% A.UpsideScore 4.3/10#9 of 9 Agricultural Inputs
QualityF-score3 / 9FCF yield1.61%
IncomeYield2.82%(5y avg 4.32%)Payout223.08%at-risk
Stop $10.80Target $14.87(analyst − 10%)A.R:R 2.3:1
Analyst target$16.52+42.4%15 analysts
$14.87our TP
$11.60price
$16.52mean
$26

Sell if holding. Engine safety override at $11.60: Quality below floor (1.7 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.3/10 and A.R:R 2.3:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 21%; Below-average business quality; Below long-term trend. Chart setup: Death cross but MACD improving, RSI 52. Score 4.3/10, moderate confidence.

Passes 7/10 gates (positive momentum, favorable risk/reward ratio, clean insider activity, news events none recent, earnings proximity 24d clear, semi cycle peak clear, materials cycle peak clear). Suitability: speculative.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Wed, Jul 29, 202624d to earnings· next earnings call

Thesis

Rewards
No bull case signals
Risks
Quality below floor (1.7 < 4.0)

Key Metrics

P/E (TTM)
P/E (Fwd)5.3
Mkt Cap$1.4B
EV/EBITDA17.2
Profit Mgn-72.9%
ROE-78.4%
Rev Growth-4.1%
Beta0.39
Dividend2.82%
Rating analysts22

Quality Signals

Piotroski F3/9

Options Flow

P/C0.60bullish
IV76%elevated

Concentration Risks(10-K Item 1A)

  • MEDIUMProductRynaxypyr® active
    10-K Item 1: 'Rynaxypyr® active (chlorantraniliprole), the world's leading insect control technology – with annual revenues of approximately $0.8 billion in 2025'
  • LOWProductCyazypyr® active
    10-K Item 1: 'Cyazypyr® active (cyantraniliprole), which supports a portfolio of products that generated revenues of approximately $0.4 billion in 2025'
  • MEDIUMSupplierChina and India intermediates
    10-K Item 1A: 'We source critical intermediates and finished products from a number of suppliers, largely outside of the U.S. and principally in China and India'

Material Events(8-K, last 90d)

  • 2026-04-29Item 5.02LOW
    Board director Dirk A. Kempthorne, a member of the FMC board since 2009, passed away. No successor named. The 2026 Incentive Stock Plan was separately approved at the April 28, 2026 Annual Meeting, replacing the 2023 plan.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

4 floor-breakers

Revenue shrinking — -4.1% YoY. Growth thesis broken unless recovery story develops.static

Revenue Growth
1.5
Declining revenue: -4%
Low model confidence on this dimension (33%).

Cyclical trough — margins compressed or negative. Profitability typically recovers with the cycle, but floor fires on current data.static

Roe
0.0
Operating Margin
0.0
Net Margin
0.0
Roa
0.6
Gross Margin
2.4
Moat
2.5
Piotroski F
3.3
Current Ratio
4.9
No competitive moatWeak Piotroski F-Score: 3/9Quality concerns

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

52w Position
0.0
Bollinger
2.8
Support Resistance
5.0

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Quality Rank
0.0
Growth Rank
0.0
Value Rank
8.9
GatesMomentum 5.4<5.5 (soft — BUY_NOW allowed but watch)Death cross (50MA < 200MA)Executive change: officer departure/appointmentMomentum 5.4>=4.5A.R:R 2.3 ≥ 1.5Insider activity: OKNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 24d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRecoverySuitability: Speculative
RSI
52 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $10.64Resistance $12.58

Price Targets

$11
$15
A.Upside+28.2%
A.R:R2.3:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Quality below floor (1.7 < 4.0)

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-07-29 (24d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is FMC stock a buy right now?

Sell if holding. Engine safety override at $11.60: Quality below floor (1.7 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.3/10 and A.R:R 2.3:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 21%; Below-average business quality; Below long-term trend. Chart setup: Death cross but MACD improving, RSI 52. Prior stop was $10.80. Score 4.3/10, moderate confidence.

What is the FMC stock price target?

Take-profit target: $14.87 (+28.1% upside). Prior stop was $10.80. Stop-loss: $10.80.

What are the risks of investing in FMC?

Quality below floor (1.7 < 4.0).

Is FMC overvalued or undervalued?

FMC Corporation trades at a P/E of N/A (forward 5.3). TrendMatrix value score: 7.1/10. Verdict: Sell.

What do analysts say about FMC?

22 analysts cover FMC with a consensus score of 3.4/5. Average price target: $17.

What does FMC Corporation do?FMC Corporation develops, markets, and sells crop protection chemicals — insecticides, herbicides, fungicides — plus...

FMC Corporation develops, markets, and sells crop protection chemicals — insecticides, herbicides, fungicides — plus biologicals and plant health products in a single global segment, employing approximately 5,500 people across four regions. Revenue comes from proprietary active ingredients; Rynaxypyr® active generated approximately $0.8 billion in 2025, with Cyazypyr® active brands at approximately $0.4 billion. In February 2026, the Board authorized a strategic review including potential sale of the company.

Related stocks: UAN (CVR Partners, LP) · ICL (ICL Group Ltd.) · SMG (Scotts Miracle-Gro Company (The) · IPI (Intrepid Potash, Inc) · MOS (Mosaic Company (The))
Home Stocks FMC

Latest news

Latest News

Benzinga6d ago
Benzinga6d ago
Benzinga14d ago
Benzinga15d agoAnalyst
Benzinga21d agoProduct
Benzinga49d ago
Benzinga61d agoMerger Acquisition
Benzinga67d agoEarnings
Benzinga67d agoAnalyst
Benzinga67d agoAnalyst
Benzinga67d agoAnalyst
Benzinga69d ago
Benzinga69d agoEarnings
Benzinga69d agoEarnings
Benzinga69d ago
Benzinga69d agoEarnings
Benzinga77d ago
Benzinga77d agoAnalyst
Benzinga78d ago
Benzinga84d ago
Loading more...